CNBC. Medtronic CEO: More companies are spinning off problems, we're spinning off an attractive asset. Posted: May 21, 2025 | Last updated: May 21, 2025 ...

Medtronic has recalled ventilators and asked customers to stop using the devices because of a fault linked to two serious ...

Medtronic warns of potential battery problem in 340,000 defibrillators. FDA says defibrillator batteries could fail early. By Joe Carlson. April 12, 2021 at 8:57PM.

Trefis estimates Medtronic’s Q4 fiscal 2023 total revenues to be around $8.2 billion, reflecting a low single-digit y-o-y rise but marginally below the $8.3 billion consensus estimate.

Medtronic on Thursday announced that the U.S. Food and Drug Administration has approved the use of its software to detect problems with defibrillator and pacemaker wires made by other manufacturers.

(AP) -- Medical device maker Medtronic is warning patients about a rare problem with its SynchroMed drug pumps that can cause them to lose battery power and fail.

Should Medtronic fail to attain the projected 4.5% revenue growth rate, it could perpetuate the problem of stagnant revenue into the foreseeable future. In my assessment, this stock is a ...